Link M S
Tufts Medical Center, NEMC Box #197, 750 Washington Street, Boston, MA 02111, USA.
Br J Sports Med. 2009 Sep;43(9):685-9. doi: 10.1136/bjsm.2008.054882.
Sudden cardiac death in the athlete is uncommon but extremely visible. In athletes under age 30, genetic heart disease, including hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and ion channel disorders account for the majority of the deaths. Commotio cordis, involving blunt trauma to the chest leading to ventricular fibrillation, is also a leading cause of sudden cardiac death in young athletes. As the athlete ages, coronary atherosclerosis contributes to an increasing incidence of sudden death during sporting activities. For athletes with aborted sudden death or arrhythmia-related syncope, an implantable cardioverter defibrillator is generally indicated, and they should be restricted from most competitive sports. Participation in competitive athletics for athletes with heart disease should generally follow the recently published 36th Bethesda Conference Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities.
运动员心源性猝死虽不常见但备受关注。在30岁以下的运动员中,遗传性心脏病,包括肥厚型心肌病、致心律失常性右室心肌病和离子通道疾病,是大多数死亡的原因。心脏震荡,即胸部钝性创伤导致心室颤动,也是年轻运动员心源性猝死的主要原因。随着运动员年龄增长,冠状动脉粥样硬化导致体育活动期间猝死的发生率增加。对于有过猝死未遂或心律失常相关晕厥的运动员,通常需要植入式心脏复律除颤器,并且他们应被限制参加大多数竞技性运动。患有心脏病的运动员参加竞技体育活动一般应遵循最近发布的第36届贝塞斯达会议关于心血管异常竞技运动员的资格建议。